The prognostic value of the suPARnostic®ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms

Table 1 Allocation of patients according to suPAR below or above median

	Low suPAR < 4.67 ng/mL (N = 40)	High suPAR ≥ 4.67 ng/mL (N = 41)	Low vs high P (Mann-Whitney U test)
suPAR (ng/ml)*	3,23 (1.22–4.65)	6.96 (4.67–12.16)
Gender (M/F)	34/6	31/10	NS
Eci-1:
G/G	24	23	NS
G/A	4	5
A/A	0	0
MspA1 l
A/A	21	16	NS
A/G	6	10
G/G	1	2
Age at suPAR meas. (years)*	28.5 (18.8–42.9)	34.5 (19.9–78.2)	< 0.001
Time from seroconversion to suPAR meas. (years)*	0.42 (0.0–4.55)	0.47 (0.0–5.72)	NS
Death within 2 years (Y/N)	0/40	13/28	< 0.001
Median (range) follow-up (years) from sample to 15^th May 1996*	5.94 (0.21 – 13.63)	5.38 (0.35 – 10.68)	NS
Death before 15^th May 1996 (Y/N)	17/23	25/16	NS

*Median (range). N = number, M/F = Male/Female, NS = non-significant, Y/N = Yes/No

ISSN: 1471-2334